On December 20, 2024 Azitra, Inc. (NYSE American: AZTR), a clinical stage biopharmaceutical company focused on developing innovative therapies for precision dermatology, reported the company will present at Biotech Showcase 2025 being held January 13-15, 2025 in San Francisco (Press release, Azitra, DEC 20, 2024, View Source [SID1234649233]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Details of the presentation are as follows:

Event:

Biotech Showcase 2025

Date and Time:

January 13, 2025 at 3:00 p.m., PT

Location:

Hilton San Francisco Union Square (Yosemite C)

Participant:

Travis Whitfill, Chief Operating Officer

Registration:

Link

During the conference, members of Azitra’s management team will conduct one-on-one meetings with registered investors and potential partners, showcasing the company’s business and clinical development strategy, recent corporate achievements, and anticipated milestones.

Biotech Showcase, produced by Demy-Colton and EBD Group, is a premier investor conference committed to creating a platform for private and micro-mid-cap biotechnology companies. It offers companies a unique opportunity to showcase their innovations and engage directly with investors and other biopharmaceutical executives.